1 / 52

Chronic pain and the opiate epidemic

Chronic pain and the opiate epidemic. Learning Objectives. Describe the history of the current epidemic of opioid use in the United States Discuss the difference between acute and chronic pain Describe steps that can be taken to help patients get off opiates.

mbrand
Download Presentation

Chronic pain and the opiate epidemic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic pain and the opiate epidemic

  2. Learning Objectives • Describe the history of the current epidemic of opioid use in the United States • Discuss the difference between acute and chronic pain • Describe steps that can be taken to help patients get off opiates After attending this presentation, learners will be able to:

  3. The biggest problem we face in treatment of pain • Opiate pain medicines relieve acute pain • Opiate pain medicines cause tolerance (loss of effectiveness over time) so the dose must be continually increased to maintain the effect • Opiate pain medications are not very effective for chronic pain • Chronic opiates can increase pain (opiate mediated hyperalgesia)

  4. “Tylox, Percocet, Vicodan, Oxycontin, and them patches, I tried ‘emall and ain’tnone of them done nothing for my pain. Which one you gonna give me?”

  5. What are the goals of treatment? • Function • Quality of life • Longevity • Comfort

  6. The Newest Opiate Epidemic • From 2000 to 2014 nearly half a million people died from drug overdoses. • 78 Americans die every day from an opioid overdose. • Overdoses from prescription opioid pain relievers are a driving factor in the 15-year increase in opioid overdose deaths. • Since 1999, the amount of prescription opioids sold in the U.S. nearly quadrupled • Deaths from prescription opioids—drugs like oxycodone, hydrocodone, and methadone—have also quadrupled since 1999

  7. In 2010 the US consumed • 99% of the world’s hydrocodone • 80 percent of the world’s oxycodone • 65 percent of the world’s hydromorphone

  8. Increased patient satisfaction correlates with increased mortality 2012 Medicare To Begin Basing Hospital Payments On Patient-Satisfaction Scores CMS says more than 3,000 hospitals will be affected. Under the proposal, patient scores would determine 30 percent of the bonuses, while clinical measures for basic quality care would set the rest. Hospitals argue the scores should have less weight, but nevertheless are trying to figure out how to improve their rankings The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Fenton JJ, Jerant AF, Bertakis KD, Franks P. Arch Intern Med. 2012 Mar 12;172(5):405-11.

  9. Doctors are Pressured to Prescribe • 71% to avoid administrative and regulatory criticism • 57% to avoid negative impact on Joint Commission surveys • 46% to avoid decreased patient satisfaction scores and decreased reimbursement • 40 % either they or one of their colleagues have been formally disciplined for failure to acquiesce to a patient's request for an opioid prescription Kelly S, Johnson GT, Harbison RD. "Pressured to prescribe" The impact of economic and regulatory factors on South-Eastern ED physicians when managing the drug seeking patient. J Emerg Trauma Shock. 2016 Apr-Jun;9(2):58-63

  10. Portenoy says he did it • “ ‘I gave innumerable lectures in the late 1980s and ‘90s about addiction that weren’t true’ ” • He argued that opioids are a ‘gift from nature’ that were being forsaken because of ‘opiophobia’ • "It had all the makings of a religious movement at the time.” • Dr. Portenoy disclosed relationships with Endo, Abbott, Cephalon, Purdue, Johnson and Johnson

  11. Where Are We Today With Evidence for Chronic Opioid Treatment? • Of the 4,209 citations identified only 39 studies could be included: • 0 RCTs comparing long term opioids to placebo • Observational studies: Many patients find opiates ineffective and have many side effects • Increased risk of abuse, overuse, fractures, MI, and the effect is dose dependent • The strength of evidence for chronic opiates was rated no higher than low *September 2014

  12. Cutting back on opiate prescriptions CDC website 2014-2015 Death increases 2014-15 New York 20.4 % increase (CDC) 2014-15 Florida 22.7 % increase (CDC) 2014-15 Tennessee 13.8 % increase (CDC) https://www.cdc.gov/drugoverdose/policy/successes.html https://www.cdc.gov/drugoverdose/data/statedeaths.html

  13. opioids

  14. Florida 22.7 % increase 2014-15

  15. Pain • Pain is made up of 2 parts: • A sensory experience associated with particular types of stimulation • An emotional response of distress and anxiety related to the sensory information

  16. Pain can be chronic or acute • Acute pain is the result of stimulation of sensory receptors for injury or trauma • Can include chronic conditions such as burns, cancer, infection, auto-immune tissue damage • Chronic pain which is the result of an adaptation of the nervous system • Pain which continues when the original injury that provoked the initial pain has resolved.

  17. Categorization of Chronic pain • Peripheral nerve dysfunction • peripheral sensitization • deafferentation • Sympathetic dysregulation- • sympathetically maintained pain • Central sensitization • sympathetic activation • cortical pain • Thalamic pain • Conditioned pain • Somatization

  18. Pain amplification • Blockade of pain sensation (opiates) • Increased sympathetic activity • Immune activation • Interference with pain “gating mechanisms” • Conditioning-learned pain • Major depression

  19. Acute pain • Tissue damage • Burns • Cancer • Trauma • Visceral stretch • Ischemia • Inflammation • Nerve activation • Toxins • Trauma • Ischemia

  20. Treatment of acute pain • Blocks • Anti-inflammatories • Steroids • Non-steroidal anti-inflammatories • Immunomodulators • Opiate analgesics • Dissociative anesthetics • Non-opiate analgesics

  21. Non-pharmacologic treatment of acute pain • Hypnosis • Acupuncture • Meditation and mindfulness • Information giving • Relaxation • Guided imagery • Breathing training • Cognitive reframing • Distraction (visual and auditory) • Massage

  22. Chronic Pain Mechanisms • Loss of large diameter myelinated sensory afferent inhibition of nociceptive transmission • Neuropathic “noise” from damaged peripheral neurons • Deafferentation hyperactivity in dorsal horn cells • Central sensitization (increased gain) • Ectopic impulse generation • sites of injury, demyelination, and regeneration • SMP  sensitivity of primary afferent nociceptors • Antidromic release of sensitizing neuromediators

  23. Approach to patients with chronic pain on opiates • Type of pain including postulated mechanism • Co-morbidities that exacerbate pain • Careful evaluation of the factors that contribute to morbidity • Provide patients with a diagnostically based treatment plan • Discussion of the goals of treatment and your role • Ideally taper all addictive symptomatic medications • Gradual engagement • EXPECT RESISTANCE

  24. Taper opiates • Opiate mediated hyperalgesia plays a role in pain • Patients with dependence may be reluctant to stop opiates • Patients with true addiction may need chronic opiate maintenance which can still produce opiate mediated hyperalgesia • Each case requires individual evaluation and a treatment tailored to the patient

  25. Chronic pain pharmacology • Most chronic pain cases respond to neuromodulators • Chronic opiates make this pain worse and prevent the response to neuromodulators

  26. Target behaviors for pain treatment • Time-contingent medications (and taper) • Graded activation (exercise) • Social reinforcement (spouse and social supports) • Self control skills • Self monitoring • Self reinforcement • Relaxation training

  27. Mastery of exercise-acquired skills • Relaxation • Imagery • Self hypnotic analgesia • Distraction techniques • Graded physical recovery exercises • Assertiveness training • Mindfulness

  28. Treat psychiatric co-morbidity • Depression • Personality vulnerabilities • Life experiences

  29. Chronic pain mechanisms Descending Modulation Brain Central α-agonists TCAs SNRIs Opioids/Tramadol Ectopic Activity Na+ channel blockers Ca+2 channel modulators GABAergic enhancement Glutaminergic inhibition CNS Central Sensitization Opioids/tramadol Central α-agonists NMDA antagonists Anticonvulsants PNS Terminal Spinal cord TCAs Anticonvulsants Local anesthetics Opioids NSAIDs Vanilloids Peripheral Sensitization Woolf C, Max M Anesthesiology 2001

  30. Issues that complicate pain treatment • Combined acute and chronic pain • Fatigue with pain management methods • Immune activation and pain amplification • Psychiatric comorbidities • Depression • Demoralization • Temperament and personality • Behavioral conditioning • Poor coping skills

  31. Demoralization and Depression

  32. Two ways to think about depression Categorical Demoralization (Sadness/Grief) Major Depression Dimensional Severity Demoralization (Sadness/Grief) Major Depression

  33. Dementia DeliriumDemoralization Inactivity Physical Deconditioning Social Isolation Loss of Function Toxicity Inflammation Depression Physical Illness Hopelessness Inactivity Physical Deconditioning Social Isolation Loss of Function Poor Compliance Impulsivity Toxicity Inflammation

  34. Cumulative Mortality for Patients With and Without Depression After Heart Attack 30 25 20 Depressed (n = 35) Mortality (%) 15 10 Non-depressed (n = 187) 5 0 0 1 2 3 4 5 6 Months After Heart Attack Frasure-Smith N, et al. JAMA. 1993;270:1819-1825; Penninx BW, et al. Arch Gen Psychiatry. 2001;58:221-227; Jiang W, et al. Arch Intern Med. 2001;161:1849-1856; Vaccarino V, et al. J Am CollCardiol. 2001;38:199-205.

  35. Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-year Period 1.00 0.99 Nondepressed (n = 5707) 0.98 Survival Probability Depressed (n = 969) 0.97 0.96 0.95 15.5 20.5 25.5 30.0 0 5.5 10.5 Survival Time Everson SA, et al. Arch Intern Med. 1998;158:1133-1138.

  36. Two Kinds of Depression Demoralization Major Depression Distractible from loss (Maintains rewards from activity) Initial insomnia No family history Unique episode Stable life course Responsive to positive events Anhedonia (Pervasive loss of rewards from activity) AM insomnia Family history Similar episodes Disrupted life course Unresponsive to positive events

  37. “I’m not depressed. If I am depressed, it is because people keep telling me I am depressed. There is nothing more depressing than being told you are depressed.”

  38. Decreased neurogenesis in stressed rats that act depressed Hippocampus Snyder et al. “Adult hippocampal neurogenesis buffers stress responses and depressive behavior” Nature, 2011

  39. Factors associated with depression • CNS inflammation • Auto-immune disease • Substance Abuse • Genetic vulnerability • Subcortical damage • Chronic illness • Stress

  40. Life Event Genes Depression Systemic illness Brain Injury

  41. Life Event Genes Depression Systemic illness Brain Injury

  42. Depression makes opiates less effective

  43. Behavior Reward

  44. Addiction Behavior Reward Depression

  45. “It is much more important to know what sort of patient has a disease than what sort of disease a patient has.” ―William Osler

  46. Simplified Model of Disposition Percent of Population Treisman GJ, Angelino AF. The Psychiatry of AIDS: A Guide to Diagnosis and Treatment. Baltimore, MD: The Johns Hopkins University Press; 2004.

More Related